Clinical Trial Update: Prostate Cancer Genomic Heterogeneity [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on genomic heterogeneity in prostate cancer spanning Phase 1 and Phase 2, with the study status marked as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University College London Hospitals | Conditions: PROSTATE CANCER | Phase 1, Phase 2 | Status: COMPLETED